Cesar A. Diaz-Galvan

Mexico City, DIF, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Prevalence of TPMT and NUDT15 diplotypes in Mexican children with B-cell acute lymphoblastic leukemia.

Prevalence of TPMT and NUDT15 diplotypes in Mexican children with B-cell acute lymphoblastic leukemia.

Journal: Pharmacogenetics and genomics

Published: February 03, 2026

Geographic and Socioeconomic Determinants of Treatment Abandonment in Pediatric Acute Leukemia: A Cohort Study in South-Central Mexico.

Geographic and Socioeconomic Determinants of Treatment Abandonment in Pediatric Acute Leukemia: A Cohort Study in South-Central Mexico.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: January 16, 2026

Targeted therapies in pediatric B-Cell acute lymphoblastic leukemia: mechanisms, efficacy, and future directions.

Targeted therapies in pediatric B-Cell acute lymphoblastic leukemia: mechanisms, efficacy, and future directions.

Journal: Frontiers in pharmacology

Published: June 26, 2025

Blinatumomab-induced remission followed by haploidentical transplantation in pediatric relapsed/refractory pre-B ALL: a multicenter study in Mexico.

Blinatumomab-induced remission followed by haploidentical transplantation in pediatric relapsed/refractory pre-B ALL: a multicenter study in Mexico.

Journal: Frontiers in oncology

Published: June 24, 2025

Hyaluronan-Mediated Motility Receptor (HMMR) Overexpression Is Correlated with Poor Survival in Patients with B-ALL.

Hyaluronan-Mediated Motility Receptor (HMMR) Overexpression Is Correlated with Poor Survival in Patients with B-ALL.

Journal: International journal of molecular sciences

Published: December 03, 2024

GATA3 germline variants in childhood pre-B acute lymphoblastic leukemia: association with CRLF2 overexpression and overweight in Mexican patients.

GATA3 germline variants in childhood pre-B acute lymphoblastic leukemia: association with CRLF2 overexpression and overweight in Mexican patients.

Journal: Frontiers in oncology

Published: November 24, 2024

Overall manifestations and survival of pediatric patients with Langerhans cell histiocytosis. A middle-income country (mic) national multicenter study.

Overall manifestations and survival of pediatric patients with Langerhans cell histiocytosis. A middle-income country (mic) national multicenter study.

Journal: Boletin medico del Hospital Infantil de Mexico

Published: November 22, 2024

Influence of SLAM Family Receptors in the NK-Cell-Mediated Surveillance of Lymphoblastic Acute Leukemia.

Influence of SLAM Family Receptors in the NK-Cell-Mediated Surveillance of Lymphoblastic Acute Leukemia.

Journal: European journal of immunology

Published: October 14, 2024

IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.

IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.

Journal: Frontiers in oncology

Published: November 13, 2023

Childhood leukemias in Mexico: towards implementing CAR-T cell therapy programs.

Childhood leukemias in Mexico: towards implementing CAR-T cell therapy programs.

Journal: Frontiers in oncology

Published: September 30, 2023

Epidemiology of childhood acute leukemias in marginalized populations of the central-south region of Mexico: results from a population-based registry.

Epidemiology of childhood acute leukemias in marginalized populations of the central-south region of Mexico: results from a population-based registry.

Journal: Frontiers in oncology

Published: September 29, 2023

Triple-hit explanation for the worse prognosis of pediatric acute lymphoblastic leukemia among Mexican and Hispanic children.

Triple-hit explanation for the worse prognosis of pediatric acute lymphoblastic leukemia among Mexican and Hispanic children.

Journal: Frontiers in oncology

Published: October 17, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026